PlexBio Co., Ltd.
6572
Rank in Stocks
#26503
PlexBio Co., Ltd. is dedicated to the creation and production of in vitro... PlexBio Co., Ltd. is dedicated to the creation and production of in vitro diagnostic (IVD) solutions for both molecular biology and immunology purposes. Their comprehensive product range features services for optimizing diagnostic workflows, as well as automated kits for sample preparation and extraction. A key innovation is their IntelliPlex platform, which leverages pCode technology to enable advanced, "sample-to-answer" multiplexing assays. The company also supplies specialized oncology panels designed for detecting lung cancer, gene mutations, and chromosomal rearrangements. Additionally, PlexBio offers a variety of infectious disease tests, including IntelliPlex kits for SARS-CoV-2 detection, influenza, and SARS-CoV-2 variant analysis, complemented by essential reagents such as pCode coupling buffer sets. Founded in 2009, PlexBio Co., Ltd. operates from its headquarters in Taipei, Taiwan.
Share Price
$0.19174725
Last synced: 2026-11-10
Market Cap
$19.87M
Change (1 day)
-2.78%
Change (1 year)
-34.69%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade PlexBio Co., Ltd. (6572)
Category
Healthcare
EPS for PlexBio Co., Ltd. (6572)
EPS as of June 2026 TTM: $-0.01
According to PlexBio Co., Ltd.'s latest financial reports, its current EPS (TTM) is $-0.01. At the end of 2025 the company had an EPS of $-0.02, equal to its 2024 EPS of $-0.02.
EPS history for PlexBio Co., Ltd. from 2013 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.01 | -43.00% |
| 2025 | $-0.02 | 6.11% |
| 2024 | $-0.02 | -1.64% |
| 2023 | $-0.02 | 10.24% |
| 2022 | $-0.02 | -63.76% |
| 2021 | $-0.05 | -6.15% |
| 2020 | $-0.05 | -37.11% |
| 2019 | $-0.08 | -29.13% |
| 2018 | $-0.11 | -25.36% |
| 2017 | $-0.15 | 20.74% |
| 2016 | $-0.12 | -23.25% |
| 2015 | $-0.16 | 50.76% |
| 2014 | $-0.11 | 106.29% |
| 2013 | $-0.05 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $8.37 | -73,521.05% |
US
|
|
| $6.02 | -52,923.68% |
FR
|
|
| $4.15 | -36,503.51% |
US
|
|
| $5.32 | -46,767.54% |
JP
|
|
| $1.29 | -11,415.79% |
CH
|
Questions about PlexBio Co., Ltd.'s earnings per share (EPS)
What is PlexBio Co., Ltd.'s earnings per share (EPS)?
PlexBio Co., Ltd.'s earnings per share (EPS) over the last twelve months is $-0.01, as of Jun 2026.
What was PlexBio Co., Ltd.'s earnings per share (EPS) in 2025?
In 2025, PlexBio Co., Ltd.'s earnings per share (EPS) was $-0.02, compared with $-0.02 in 2024.
How has PlexBio Co., Ltd.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, PlexBio Co., Ltd.'s earnings per share (EPS) was highest in 2025 ($-0.02) and lowest in 2021 ($-0.05).
How does PlexBio Co., Ltd.'s earnings per share (EPS) compare with similar companies?
PlexBio Co., Ltd.'s earnings per share (EPS) ($-0.01) is lower than that of all 5 similar companies listed above. The highest among them is Intuitive Surgical, Inc., with $8.37.